Gastrointestinal Cancer
Current Clinical Trials
Curie Research by Curie Oncology
Clinical Trial – Gastrointestinal Cancer
| Protocol Name / No. | Protocol Title | Principal Investigator |
|---|---|---|
| CA266-0003 | A Blinded, Randomized Phase 2/3 Study of BMS-986545 (BNT327) in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer NCT number: https://clinicaltrials.gov/study/NCT07221357 | Dr Choo Su Pin |
| RASolute 303 (RMC-6236-303) | A Phase 3 Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel Q2W versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) NCT number: https://clinicaltrials.gov/study/NCT07491445 | Dr Choo Su Pin |